These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8275659

  • 1. [Tauro-ursodeoxycholic acid vs. ursodeoxycholic acid in the dissolution of biliary calculi. Results of a single blind study].
    Gallo V, De Micheli AG, Chiandussi L.
    Clin Ter; 1993 Nov; 143(5):421-8. PubMed ID: 8275659
    [Abstract] [Full Text] [Related]

  • 2. [Taurodeoxycholic acid in the treatment of primary biliary cirrhosis. A controlled study in comparison to ursodeoxycholic acid].
    Ferri F, Bernocchi P, Fedeli S.
    Clin Ter; 1993 Oct; 143(4):321-6. PubMed ID: 8258267
    [Abstract] [Full Text] [Related]

  • 3. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S, Abei M, Yamaguchi T, Matsuzaki Y, Shoda J, Tanaka N, Osuga T.
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
    Venneman NG, Besselink MG, Keulemans YC, Vanberge-Henegouwen GP, Boermeester MA, Broeders IA, Go PM, van Erpecum KJ.
    Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
    [Abstract] [Full Text] [Related]

  • 5. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
    Bazzoli F, Festi D, Mazzella G, Frabboni R, Zagari RM, Fossi S, Pozzato P, Sottili S, Simoni P, Roda A.
    Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
    [Abstract] [Full Text] [Related]

  • 6. [Recurrence of vesicular microlithiasis. Controlled study with different dosis of ursodeoxycholic acid].
    Guma C, Viola L, Thomé M, Galdame O, Facelli A, Di Bucci A, Vaimberg D.
    Medicina (B Aires); 1998 Jun; 58(5 Pt 1):474-6. PubMed ID: 9922479
    [Abstract] [Full Text] [Related]

  • 7. Effect of tauroursodeoxycholic acid (TUDCA) on biliary lipid composition.
    Muraca M, Vilei MT, Cianci V, Liu XT.
    Ital J Gastroenterol; 1995 Jun; 27(8):439-40. PubMed ID: 8775471
    [Abstract] [Full Text] [Related]

  • 8. [Rationale for the use of bile salts after cholecystectomy: results of a controlled clinical study using tauroursodeoxycholic acid (TUDCA)].
    Croce E, Golia M, Trignano M, Occhioni G, Pisano J, La Rocca R, Capomagi A, De Sanctis A, Morino M, Fornari M.
    Ann Ital Chir; 1993 Jun; 64(5):533-7. PubMed ID: 8010582
    [Abstract] [Full Text] [Related]

  • 9. [Bile acid therapy vs. placebo before and after extracorporeal shock wave lithotripsy of gallbladder stones].
    Ugeskr Laeger; 1998 Jun 01; 160(23):3408-12. PubMed ID: 9627510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of dyspeptic disorders, lithiasis and biliary dyskinesia with ursodeoxycholic acid. Analysis of a controlled multicenter study].
    Realini S, Reiner M, Frigerio G.
    Schweiz Med Wochenschr; 1980 May 31; 110(22):879-80. PubMed ID: 6996086
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A.
    Hepatology; 1996 Jun 31; 23(6):1484-90. PubMed ID: 8675168
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G, Roulot D, Davion T, Masliah C, Causse X, Oberti F, Raabe JJ, Van Lemmens C, Labadie H, Serfaty L, URSOMAF Group.
    Hepatology; 2003 Apr 31; 37(4):887-92. PubMed ID: 12668982
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary experience with the use of ursodeoxycholic acid in the treatment of biliary calculosis].
    Bonfiglio M, Casamichiela M, Garagnani A.
    Clin Ter; 1979 Mar 15; 88(5):491-7. PubMed ID: 466971
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.
    Pan XL, Zhao L, Li L, Li AH, Ye J, Yang L, Xu KS, Hou XH.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Apr 15; 33(2):189-194. PubMed ID: 23592128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.